Denosumab Treatment for Fibrous Dysplasia
Denosumab Treatment for Fibrous Dysplasia
Active, not recruiting · NCT03571191 · Registry updated 2022-02-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Denosumab Treatment for Fibrous Dysplasia | Bone Diseases, Developmental, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, bone disorder, fibrous dysplasia, musculoskeletal system disorder, osteochondrodysplasia | Active, not recruiting | Phase 2 | 2022-02-18 | NCT03571191 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Dental and Craniofacial Research (NIDCR) | 62 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | United States | 800 |